201 related articles for article (PubMed ID: 35295808)
1. Inhibition of Nociception in a Preclinical Episodic Migraine Model by Dietary Supplementation of Grape Seed Extract Involves Activation of Endocannabinoid Receptors.
Woodman SE; Antonopoulos SR; Durham PL
Front Pain Res (Lausanne); 2022; 3():809352. PubMed ID: 35295808
[TBL] [Abstract][Full Text] [Related]
2. 5-HT3/7 and GABA
Cornelison LE; Woodman SE; Durham PL
Nutr Neurosci; 2022 Aug; 25(8):1565-1576. PubMed ID: 33544064
[No Abstract] [Full Text] [Related]
3. A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.
Kopruszinski CM; Navratilova E; Swiokla J; Dodick DW; Chessell IP; Porreca F
Cephalalgia; 2021 Mar; 41(3):305-317. PubMed ID: 32985222
[TBL] [Abstract][Full Text] [Related]
4. Grape seed extract suppresses calcitonin gene-related peptide secretion and upregulates expression of GAD 65/67 and GABAB receptor in primary trigeminal ganglion cultures.
Antonopoulos SR; Durham PL
IBRO Neurosci Rep; 2022 Dec; 13():187-197. PubMed ID: 36093283
[TBL] [Abstract][Full Text] [Related]
5. Dietary supplementation with grape seed extract prevents development of trigeminal sensitization and inhibits pain signaling in a preclinical chronic temporomandibular disorder model.
Cornelison LE; Chelliboina N; Woodman SE; Durham PL
J Oral Pathol Med; 2020 Jul; 49(6):514-521. PubMed ID: 32531825
[TBL] [Abstract][Full Text] [Related]
6. Dietary supplementation with grape seed extract from Vitus vinifera prevents suppression of GABAergic protein expression in female Sprague Dawley trigeminal ganglion in a model of chronic temporomandibular joint disorder.
Antonopoulos SR; Garten DA; Durham PL
Arch Oral Biol; 2024 Sep; 165():106014. PubMed ID: 38833771
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Trigeminal Nociception by Non-invasive Vagus Nerve Stimulation: Investigating the Role of GABAergic and Serotonergic Pathways in a Model of Episodic Migraine.
Cornelison LE; Woodman SE; Durham PL
Front Neurol; 2020; 11():146. PubMed ID: 32194498
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effect of Enriched Chicken Bone Broth as a Dietary Supplement in a Model of Migraine Mediated by Early Life Stress.
Peterson OJ; Cornelison LE; Durham PL
J Med Food; 2020 Dec; 23(12):1259-1265. PubMed ID: 32326809
[TBL] [Abstract][Full Text] [Related]
9. Vagus nerve stimulation inhibits trigeminal nociception in a rodent model of episodic migraine.
Hawkins JL; Cornelison LE; Blankenship BA; Durham PL
Pain Rep; 2017 Nov; 2(6):e628. PubMed ID: 29392242
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of calcitonin gene-related peptide in upper spinal cord promotes sensitization of primary trigeminal nociceptive neurons.
Cornelison LE; Hawkins JL; Durham PL
Neuroscience; 2016 Dec; 339():491-501. PubMed ID: 27746346
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive vagus nerve stimulation and morphine transiently inhibit trigeminal pain signaling in a chronic headache model.
Cornelison LE; Hawkins JL; Woodman SE; Durham PL
Pain Rep; 2020; 5(6):e881. PubMed ID: 33364541
[TBL] [Abstract][Full Text] [Related]
12. Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine.
Kopruszinski CM; Thornton P; Arnold J; Newton P; Lowne D; Navratilova E; Swiokla J; Dodick DW; Dobson C; Gurrell I; Chessell IP; Porreca F
Cephalalgia; 2020 Dec; 40(14):1535-1550. PubMed ID: 33131305
[TBL] [Abstract][Full Text] [Related]
13. Receptor mechanisms mediating the anti-neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine.
Kilinc E; Ankarali S; Torun IE; Dagistan Y
Eur J Neurosci; 2022 Feb; 55(4):1015-1031. PubMed ID: 32639078
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine.
Watanabe M; Kopruszinski CM; Moutal A; Ikegami D; Khanna R; Chen Y; Ross S; Mackenzie K; Stratton J; Dodick DW; Navratilova E; Porreca F
Brain; 2022 Aug; 145(8):2894-2909. PubMed ID: 35325034
[TBL] [Abstract][Full Text] [Related]
15. A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: Role of CGRP in orofacial pain.
Romero-Reyes M; Pardi V; Akerman S
Exp Neurol; 2015 Sep; 271():95-103. PubMed ID: 25981890
[TBL] [Abstract][Full Text] [Related]
16. Dual orexin receptor antagonist 12 inhibits expression of proteins in neurons and glia implicated in peripheral and central sensitization.
Cady RJ; Denson JE; Sullivan LQ; Durham PL
Neuroscience; 2014 Jun; 269():79-92. PubMed ID: 24685439
[TBL] [Abstract][Full Text] [Related]
17. Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing.
Greco R; Demartini C; Zanaboni AM; Tassorelli C
J Headache Pain; 2018 Jul; 19(1):51. PubMed ID: 30003352
[TBL] [Abstract][Full Text] [Related]
18. Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment.
Durham PL; Masterson CG
Headache; 2013 Jan; 53(1):67-80. PubMed ID: 23095108
[TBL] [Abstract][Full Text] [Related]
19. Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine.
Zhang Q; Han X; Wu H; Zhang M; Hu G; Dong Z; Yu S
Mol Pain; 2019; 15():1744806918820452. PubMed ID: 30799680
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic mechanisms of trigeminal meningeal nociception: Implications for migraine pain.
Kilinc E; Guerrero-Toro C; Zakharov A; Vitale C; Gubert-Olive M; Koroleva K; Timonina A; Luz LL; Shelukhina I; Giniatullina R; Tore F; Safronov BV; Giniatullin R
Neuropharmacology; 2017 Apr; 116():160-173. PubMed ID: 28025094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
